Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases
Funds short, exploratory clinical trials — from first-in-human through Phase II — for arthritis, musculoskeletal and skin disease treatments.
Between a promising idea and a full clinical program sits a short, exploratory trial that tells you whether the idea survives contact with a real patient. This notice funds that stage for NIAMS's diseases specifically.
The Exploratory Clinical Trials Grants Program supports research toward preventing or reducing symptoms and improving outcomes and function in patients with rheumatic, musculoskele…
Short-term, interventional exploratory clinical trials — proof-of-concept, first-in-human, and Phase I or II studies of drugs, biologics, devices, behavioral interventions or physical therapy — for the prevention, diagnosis or treatment of rheumatic, musculoskeletal or skin conditions, including trials in rare diseases and biomarker predictive-value studies. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIH
All grants from this funder →GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
🇺🇸NIH · United States
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
🇺🇸NIH · United States
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)
NIH · United States
Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.
Similar grants
Browse the directory →
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.
NIOSH Exploratory/Developmental OSH Grant
🇺🇸NIOSH · United States
Supports exploratory and developmental grants for novel approaches in occupational safety and health research.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
NIOSH WTC Health Program — R21 Exploratory Grant
🇺🇸NIOSH · United States
Funds exploratory clinical studies improving diagnostics and treatments from disaster-related conditions.
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
🇺🇸FDA OOPD · United States
Funds natural-history studies that improve preparedness for rare disease trial pathways.
Doctoral Clinical Fellowship
🇬🇧ARUK · United Kingdom
Supports doctoral fellowships focused on dementia research, diagnosis, treatment, and prevention in clinical settings.